Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · University of Brescia · +1 more institution
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
790
total citations
- FWCI
- 18.96
- Percentile
- 100%
- References
- 27
Citations per year
Authors
63- PTPaola ToniatiCorresponding
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
- SPSimone Piva
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia
- MCMarco Cattalini
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia
- EGEmirena Garrafa
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia
- FRFrancesca Regola
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia
Topics & keywords
Topics
Keywords
- Medicine
- Tocilizumab
- ARDS
- Pneumonia
- Intensive care unit
- Mechanical ventilation
- Internal medicine
- Respiratory failure
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.